CCM
VRXAW

Context Capital Management’s Veraxa Biotech AG Warrants VRXAW Stock Holding History

Context Capital Management’s Portfolio VRXAW Stock Details VRXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
+100,000
New +$17.6K ﹤0.01% 393

Other funds holding VRXAW

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return

Context Capital Management's VRXAW Position: Q2 2026 in Review

Context Capital Management opened a new position in Veraxa Biotech AG Warrants (VRXAW) in Q2 2026: 100,000 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #393 among its holdings.

4 funds tracked by Wall St. Rank hold VRXAW as of Q2 2026.

  • Context Capital Management held 100,000 shares of Veraxa Biotech AG Warrants worth $11K as of Q2 2026.
  • Veraxa Biotech AG Warrants was a new Context Capital Management position in Q2 2026.
  • Veraxa Biotech AG Warrants made up ﹤0.01% of Context Capital Management's portfolio in Q2 2026, its #393 holding.
  • 4 funds tracked by Wall St. Rank held Veraxa Biotech AG Warrants as of Q2 2026.

Based on Context Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.